Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-972
Closed -$242K 91
2021
Q1
$242K Buy
972
+25
+3% +$5.96K 0.05% 81
2020
Q4
$218K Sell
947
-1,367
-59% -$315K 0.05% 65
2020
Q3
$588K Buy
2,314
+1
+0% +$248 0.14% 53
2020
Q2
$545K Buy
2,313
+2
+0.1% +$456 0.14% 52
2020
Q1
$468K Sell
2,311
-135
-6% -$29.5K 0.14% 50
2019
Q4
$590K Sell
2,446
-41
-2% -$9.04K 0.18% 37
2019
Q3
$481K Sell
2,487
-482
-16% -$92.5K 0.14% 56
2019
Q2
$547K Sell
2,969
-186
-6% -$33.3K 0.16% 55
2019
Q1
$599K Sell
3,155
-726
-19% -$139K 0.19% 56
2018
Q4
$756K Buy
+3,881
New +$757K 0.29% 49

Other funds holding AMGN

MA Private Wealth's AMGN Position: Q2 2021 in Review

MA Private Wealth sold out of Amgen (AMGN) in Q2 2021, closing a stake of 972 shares — an estimated $242K sold.

MA Private Wealth first reported a position in AMGN in Q4 2018 and held it in 10 quarters. The position peaked at $756K in Q4 2018. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • MA Private Wealth reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
  • MA Private Wealth sold 972 Amgen shares in Q2 2021, an estimated $242K.
  • MA Private Wealth first reported a position in Amgen in Q4 2018 and held it in 10 quarters.
  • MA Private Wealth's Amgen position peaked at $756K in Q4 2018.
  • 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on MA Private Wealth's 13F filing for Q2 2021, filed 22 Jul 2021.